MODEL-PREDICTED LYMPHOCYTE RESPONSE AND RECOVERY PROFILES FOR THE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATORS OZANIMOD AND ETRASIMOD

Caroline A. Lee  1     Timothy Waterhouse  2     Michael Heathman  2     D. Alex Oh  2     Kiyomi Komori  2     John S. Grundy  2    
1 Arena Pharmaceuticals, a wholly-owned subsidiary of Pfizer Inc, New York, San Diego, United States
2 Metrum Research Group, Tariffville, United States

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing